For citations:
Prokopyev A.E., Shatilova A.A., Budaeva I.G., Reshetova A.I., Badaev R.Sh., Motorin D.V., Kovalchuk K.A., Ershova A.E., Tochenaya E.N., Ivanov V.V., Bogdanov K.V., Mirolyubova Yu.V., Tolstopyatova E.V., Nikulina T.S., Alekseeva Yu.A., Girshova L.L. Triple targeted therapy is a new perspective treatment strategy for patients with FLT3-mutated acute myeloid leukemia. the literature review and single-centre experience. Russian Journal for Personalized Medicine. 2022;2(4):63-76. (In Russ.) https://doi.org/10.18705/2782-3806-2022-2-4-63-86
Email this article 